22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quorum Sensing Down-Regulation Counteracts the Negative Impact of Pseudomonas aeruginosa on CFTR Channel Expression, Function and Rescue in Human Airway Epithelial Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The function of cystic fibrosis transmembrane conductance regulator (CFTR) channels is crucial in human airways. However unfortunately, chronic Pseudomonas aeruginosa infection has been shown to impair CFTR proteins in non-CF airway epithelial cells (AEC) and to alter the efficiency of new treatments with CFTR modulators designed to correct the basic CFTR default in AEC from cystic fibrosis (CF) patients carrying the F508del mutation. Our aim was first to compare the effect of laboratory strains, clinical isolates, engineered and natural mutants to determine the role of the LasR quorum sensing system in CFTR impairment, and second, to test the efficiency of a quorum sensing inhibitor to counteract the deleterious impact of P. aeruginosa both on wt-CFTR and on the rescue of F508del-CFTR by correctors. We first report that exoproducts from either the laboratory PAO1 strain or a clinical ≪Early≫ isolate (from an early stage of infection) altered CFTR expression, localization and function in AEC expressing wt-CFTR. Genetic inactivation of the quorum-sensing LasR in PAO1 (PAO1Δ lasR) or in a natural clinical mutant (≪Late≫ CF-adapted clinical isolate) abolished wt-CFTR impairment. PAO1 exoproducts also dampened F508del-CFTR rescue by VRT-325 or Vx-809 correctors in CF cells, whereas PAO1Δ lasR had no impact. Importantly, treatment of P. aeruginosa cultures with a quorum sensing inhibitor (HDMF) prevented the negative effect of P. aeruginosa exoproducts on wt-CFTR and preserved CFTR rescue by correctors in CF AEC. These findings indicate that LasR-interfering strategies could be of benefits to counteract the deleterious effect of P. aeruginosa in infected patients.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Bacterial quorum sensing: its role in virulence and possibilities for its control.

          Quorum sensing is a process of cell-cell communication that allows bacteria to share information about cell density and adjust gene expression accordingly. This process enables bacteria to express energetically expensive processes as a collective only when the impact of those processes on the environment or on a host will be maximized. Among the many traits controlled by quorum sensing is the expression of virulence factors by pathogenic bacteria. Here we review the quorum-sensing circuits of Staphylococcus aureus, Bacillus cereus, Pseudomonas aeruginosa, and Vibrio cholerae. We outline these canonical quorum-sensing mechanisms and how each uniquely controls virulence factor production. Additionally, we examine recent efforts to inhibit quorum sensing in these pathogens with the goal of designing novel antimicrobial therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

            The airways of patients with cystic fibrosis (CF) are nearly always infected with many different microorganisms. This environment offers warm, humid and nutrient-rich conditions, but is also stressful owing to frequent antibiotic therapy and the host immune response. Pseudomonas aeruginosa is commonly isolated from the airways of patients with CF, where it most often establishes chronic infections that usually persist for the rest of the lives of the patients. This bacterium is a major cause of mortality and morbidity and has therefore been studied intensely. Here, we discuss how P. aeruginosa evolves from a state of early, recurrent intermittent colonization of the airways of patients with CF to a chronic infection state, and how this process offers opportunities to study bacterial evolution in natural environments. We believe that such studies are valuable not only for our understanding of bacterial evolution but also for the future development of new therapeutic strategies to treat severe chronic infections.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

              Cystic fibrosis is a life-limiting disease that is caused by defective or deficient cystic fibrosis transmembrane conductance regulator (CFTR) protein activity. Phe508del is the most common CFTR mutation.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cell Infect Microbiol
                Front Cell Infect Microbiol
                Front. Cell. Infect. Microbiol.
                Frontiers in Cellular and Infection Microbiology
                Frontiers Media S.A.
                2235-2988
                10 November 2017
                2017
                : 7
                : 470
                Affiliations
                [1] 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal , Montréal, QC, Canada
                [2] 2Département de Médecine, Université de Montréal , Montréal, QC, Canada
                [3] 3Meakins-Christie Laboratories at the Research Institute of the McGill University Health Centre , Montréal, QC, Canada
                [4] 4Department of Medicine, McGill University , Montréal, QC, Canada
                Author notes

                Edited by: Amal O. Amer, Department of Internal Medicine, Wexner Medical Center, Ohio State University, United States

                Reviewed by: Gill Diamond, University of Florida, United States; Silvia T. Cardona, University of Manitoba, Canada

                *Correspondence: Emmanuelle Brochiero emmanuelle.brochiero@ 123456umontreal.ca
                Article
                10.3389/fcimb.2017.00470
                5686086
                29177135
                b1caf790-fb05-46d1-aff9-69afe39efa0b
                Copyright © 2017 Maillé, Ruffin, Adam, Messaoud, Lafayette, McKay, Nguyen and Brochiero.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 03 August 2017
                : 27 October 2017
                Page count
                Figures: 7, Tables: 1, Equations: 0, References: 43, Pages: 14, Words: 8527
                Funding
                Funded by: Canadian Institutes of Health Research 10.13039/501100000024
                Award ID: PJT148593
                Funded by: Cystic Fibrosis Canada 10.13039/501100000082
                Award ID: 2368
                Funded by: Association Vaincre la Mucoviscidose 10.13039/501100006342
                Award ID: RF20160501674
                Funded by: Fonds de Recherche du Québec - Santé 10.13039/501100000156
                Funded by: Université de Montréal 10.13039/501100005242
                Categories
                Microbiology
                Original Research

                Infectious disease & Microbiology
                cystic fibrosis,p. aeruginosa,infection,cftr,vx-809,correctors,lasr,furanone
                Infectious disease & Microbiology
                cystic fibrosis, p. aeruginosa, infection, cftr, vx-809, correctors, lasr, furanone

                Comments

                Comment on this article